A61K 31/4192
1,2,3-triazoles
Official title: 1,2,3-Triazoles
A61K31/4192 (1,2,3-triazoles) appears on 693 US grants and 1,165 published applications in this corpus.
Search patents in A61K- Granted patents
- 693
- Published applications
- 1,165
- Assignees
- 552
- Inventors
- 2,903
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 7 | 0 |
| 2000 | 9 | 0 |
| 2001 | 4 | 0 |
| 2002 | 3 | 3 |
| 2003 | 3 | 13 |
| 2004 | 2 | 13 |
| 2005 | 4 | 14 |
| 2006 | 7 | 10 |
| 2007 | 5 | 17 |
| 2008 | 3 | 9 |
| 2009 | 2 | 22 |
| 2010 | 13 | 29 |
| 2011 | 10 | 37 |
| 2012 | 15 | 40 |
| 2013 | 35 | 47 |
| 2014 | 36 | 66 |
| 2015 | 45 | 92 |
| 2016 | 37 | 71 |
| 2017 | 69 | 72 |
| 2018 | 61 | 76 |
| 2019 | 60 | 71 |
| 2020 | 53 | 56 |
| 2021 | 34 | 66 |
| 2022 | 35 | 54 |
| 2023 | 33 | 68 |
| 2024 | 39 | 84 |
| 2025 | 32 | 67 |
| 2026 | 22 | 68 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tubulin polymerization inhibitor for cancer therapy29 Sep 2026US 12,746,228 B2Board of Regents, The University of Texas System
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain18 Aug 2026US 12,708,632 B2Jazz Pharmaceuticals Research UK Limited
- Methods of treating cancer using androgen receptor antagonists4 Aug 2026US 12,697,322 B2Garvan Institute of Medical Research
- Benzimidazole inhibitors of PAD enzymes28 Jul 2026US 12,692,254 B2
- Compositions comprising modulators of ribonucleoprotein granule formation and dissolution and methods of use thereof1 Oct 2026US 2026/0294874 A1University of Virginia Patent Foundation
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Testosterone and difluoromethylornithine combination therapy for prostate cancer24 Sep 2026US 2026/0284076 A1The Johns Hopkins University
- Crystalline forms of a 1h-1,2,3-triazole-4-carboxylic acid compound24 Sep 2026US 2026/0285817 A1
- Butenolide-based estrogen receptor alpha inhibitors and degraders and method of using the same24 Sep 2026US 2026/0285824 A1Georgia Tech Research Corporation
Most cited
By later US patents
- Indole derivatives as CFTR modulators130US 7,645,789 B2Vertex Pharmaceuticals Incorporated · 2010
- Trans-scleral drug delivery method and apparatus84US 7,276,050 B22007
- Compositions and methods for treatment of eye disorders84US 8,168,655 B2Sarcode Bioscience Inc. · 2012
- Modulators of ATP-binding cassette transporters82US 8,415,387 B2Vertex Pharmaceuticals Incorporated · 2013
- Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA76US 8,211,401 B2Molecular Insight Pharmaceuticals, Inc. · 2012